A human model of platelet-leucocyte adhesive interactions during controlled ischaemia in patients with peripheral vascular disease

Journal of Clinical Pathology

Volumn 55, Issue 12, 2002, Pages 946-950

  Pasqualini, L ^a   Pirro, M ^a   Lombardini, R ^a   Ciuffetti, G ^a   Dragani, P ^a   Mannarino, E ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CLOPIDOGREL;

ADULT; ARTICLE; BLOOD VISCOSITY; CELL INTERACTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN CELL; ISCHEMIA; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MICROVASCULATURE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHEAR RATE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; TIME; TISSUE PERFUSION; TRANSCUTANEOUS OXYGEN MONITORING; TREADMILL EXERCISE; WALKING;

ADULT; ARTERIAL OCCLUSIVE DISEASES; BLOOD PLATELETS; BLOOD VISCOSITY; CELL ADHESION; DOUBLE-BLIND METHOD; EXERCISE TEST; HUMANS; LEUKOCYTES; MALE; MICROCIRCULATION; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PERIPHERAL VASCULAR DISEASES; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 0036903416     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.12.946     Document Type: Article

References (24)

1. Piccardoni P, Evangelista V, Piccoli A, et al. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes. Thromb Haemost 1996;76:780-5.
2. Cerletti C, Evangelista V, De Gaetano G. P-selectin-beta 2-integrin cross-talk: A molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost 1999;82:787-93.
3. Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost 1995;74:224-7.
4. Blann AD, Lip GY. Hypothesis: Is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997;128:135-8.
5. Chang RR, Chien NT, Chen CH, et al. Spontaneous activation of circulating granulocytes in patients with acute myocardial and cerebral diseases. Biorheology 1992;29:549-61.
6. Lentsch AB, Miller FN, Edwards MJ. Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2. Cancer Immunol Immunother 1999;47:243-8.
7. Patterson E, Burow RD, Hung CY, et al. Coronary vascular iniury after transient coronary artery occlusion. Lab Invest 1993;69:471-82.
8. Gurney D, Lip GY, Blann AD. A reliable plasma marker of platelet activation: Does it exist? Am J Hematol 2002;70:139-44.
9. Viedma Contreras JA. Leucocyte activation markers in clinical practice. Clin Chem Lab Med 1999;37:607-22.
10. Reinhart WH. Hemorheology: Blood flow haematology. Schweiz Med Wochenschr 1995;125:387-95.
11. Brun JF, Bouchahda C, Aissa-Benhaddad A, et al. Hemorheological aspects of leuko-platelet activation in atheromatous diseases: Clinical applications. J Mal Vasc 2000;25:349-55.
12. Mchedlishvili G. Disturbed blood flow structuring as critical factor of hemorheological disorders in microcirculation. Clin Hemorheol Microcirc 1998;19:315-25.
13. Ciuffetti G, Mercuri M, Mannarino E, et al. Are leucocyte-derived free radicals involved in ischaemia in human legs? Eur J Clin Invest 1991;21:111-17.
14. Kirkpatrick UJ, Mossa M, Blann AD, et al. Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication. Thromb Haemost 1997;78:1338-42.
15. Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 1999;120:1667-72.
16. Ciuffetti G, Paltriccia R, Lombardini R, et al. Treating peripheral arterial occlusive disease: Pentoxifylline vs exercise. Int Angiol 1994;13:33-9.
17. Artmann A, Kuschinsky W. Cerebral Ischemia and Hemorheology. Berlin: Springer-Verlag, 1987.
18. Guidelines on selection of laboratory tests for monitoring the acute phase response. International committee for standardization in haematology (expert panel on blood rheology). J Clin Pathol 1988;41:1203-12.
19. Abramson S, Edelson H, Kaplan H, et al. The inactivation of the polymorphonuclear leukocyte by non-steroidal anti-inflammatory drugs. Inflammation 1984;8(suppl):S103-8.
20. Mikita J, Nash G, Dormandy J. A simple method of preparing white blood cells for filterability testing. Clin Hemorheol 1986;6:635-9.
21. Kenny MW, Meakir M, Stuart J. Measurement of erythrocyte filterability using washed-erythrocyte and whole blood methods. Clin Hemorheol 1981;1:135-9.
22. Lennie SE, Lowe GDO, Barbenel JC, et al. Filterability of white blood cell subpopulations, separated by an improved method. Clin Hemorheol 1987;7:811-16.
23. Caimi G, Lo Presti R, Serra A, et al. Red cell filterability and erythrocyte membrane microviscosity during ticlopidine treatment. J Int Med Res 1990;18:161-3.
24. Ciuffetti G, Lombardini R, Pirro M, et al. Clopidogrel: Hemorheological effects in subjects with subclinical atherosclerosis. Clin Haemorheol 2001;25:31-9.